Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Hedelin, Maria ^a,b   Löf, Marie ^c   Olsson, Marita ^c,d   Lewander, Tommy ^a   Nilsson, Björn ^a   Hultman, Christina M ^a,c   Weiderpass, Elisabete ^b,c,e,f  

^a UPPSALA UNIVERSITY   (Sweden)

^b Samfundet Folkhälsan ^*  (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FISH; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HERRING; HIGH RISK POPULATION; HUMAN; MACKEREL; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PSYCHOSIS; RISK REDUCTION; SALMON; SWEDEN; ANIMAL; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; DIET; FAT INTAKE; FEEDING BEHAVIOR; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; SCHIZOPHRENIA; SEA FOOD; STATISTICS;

ADULT; ANIMALS; COHORT STUDIES; DIET; DIET SURVEYS; DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; FOOD HABITS; HUMANS; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RISK FACTORS; SCHIZOPHRENIA; SEAFOOD; SWEDEN; VITAMIN D;

EID: 77952598731     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-38     Document Type: Article

References (60)

1. Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, Verdoux H, Van Os J. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002, 32(2):347-358. 10.1017/S0033291701005141, 11866327.
2. Hanssen MS, Bijl RV, Vollebergh W, van Os J. Self-reported psychotic experiences in the general population: a valid screening tool for DSM-III-R psychotic disorders?. Acta Psychiatr Scand 2003, 107(5):369-377. 10.1034/j.1600-0447.2003.00058.x, 12752033.
3. Sommer IE, Daalman K, Rietkerk T, Diederen KM, Bakker S, Wijkstra J, Boks MP. Healthy Individuals With Auditory Verbal Hallucinations; Who Are They? Psychiatric Assessments of a Selected Sample of 103 Subjects. Schizophr Bull 2008,
4. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239. 10.1016/S0140-6736(09)60072-6, 19150704.
5. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 2007, 42(2):117-124. 10.1007/s00127-006-0135-2, 17187169.
6. Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. Br J Psychiatry 2004, 184:404-408. 10.1192/bjp.184.5.404, 15123503.
7. Rossler W, Riecher-Rossler A, Angst J, Murray R, Gamma A, Eich D, van Os J, Gross VA. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007, 92(1-3):1-14. 10.1016/j.schres.2007.01.002, 17363221.
8. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009, 39(2):179-195. 10.1017/S0033291708003814, 18606047.
9. Lataster T, Myin-Germeys I, Derom C, Thiery E, van Os J. Evidence that self-reported psychotic experiences represent the transitory developmental expression of genetic liability to psychosis in the general population. Am J Med Genet B Neuropsychiatr Genet 2009, 150B(8):1078-1084. 10.1002/ajmg.b.30933, 19229852.
10. Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C, Golding J. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007, 369(9561):578-585. 10.1016/S0140-6736(07)60277-3, 17307104.
11. Koenen KC, Moffitt TE, Roberts AL, Martin LT, Kubzansky L, Harrington H, Poulton R, Caspi A. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am J Psychiatry 2009, 166(1):50-57. 10.1176/appi.ajp.2008.08030343, 2705657, 19047325.
12. Kinney DK, Teixeira P, Hsu D, Napoleon SC, Crowley DJ, Miller A, Hyman W, Huang E. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?. Schizophr Bull 2009, 35(3):582-595. 10.1093/schbul/sbp023, 2669590, 19357239.
13. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998, 30(3):193-208. 10.1016/S0920-9964(97)00151-5, 9589514.
14. Christensen O, Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 1988, 78(5):587-591. 10.1111/j.1600-0447.1988.tb06388.x, 3232536.
15. Stokes C, Peet M. Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutr Neurosci 2004, 7(4):247-249. 10.1080/10284150400010012, 15682652.
16. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 2000, 47(1):8-21. 10.1016/S0006-3223(99)00092-X, 10650444.
17. Joy CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid supplementation for schizophrenia. Cochrane Database Syst Rev 2006, 3:CD001257.
18. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr Res 1999, 40(3):173-177. 10.1016/S0920-9964(99)00052-3, 10638855.
19. Lagiou P, Trichopoulos D, Sandin S, Lagiou A, Mucci L, Wolk A, Weiderpass E, Adami HO. Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr 2006, 96(2):384-392. 10.1079/BJN20061824, 16923235.
20. Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1375-1381.
21. Ekman A, Dickman PW, Klint A, Weiderpass E, Litton JE. Feasibility of using web-based questionnaires in large population-based epidemiological studies. Eur J Epidemiol 2006, 21(2):103-111. 10.1007/s10654-005-6030-4, 16518678.
22. Peters ER, Joseph SA, Garety PA. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr Bull 1999, 25(3):553-576.
23. Wing JK, Cooper JE, Sartorius N. Measurement and Classification of Psychiatric Symptoms. 1974, Cambridge: Cambridge University Press, 1.
24. Konings M, Bak M, Hanssen M, van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 2006, 114(1):55-61. 10.1111/j.1600-0447.2005.00741.x, 16774662.
25. Brenner K, Schmitz N, Pawliuk N, Fathalli F, Joober R, Ciampi A, King S. Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr Res 2007, 95(1-3):86-95. 10.1016/j.schres.2007.06.017, 17693059.
26. Wolk A, Bergstrom R, Hunter D, Willett W, Ljung H, Holmberg L, Bergkvist L, Bruce A, Adami HO. A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med 1998, 158(1):41-45. 10.1001/archinte.158.1.41, 9437377.
27. National Food Administration, Sweden National Food Administration, Sweden., http://www.slv.se/en-gb/
28. Willet W. Nutritional Epidemiology. 1998, New York: Oxford University Press, 2.
29. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998, 48(2-3):149-155. 10.1016/S0165-0327(97)00166-3, 9543204.
30. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999, 29(3):697-701. 10.1017/S0033291798008186, 10405091.
31. Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, Louie P, Cather C, Eden Evins A, Freudenreich O, Taber SM, Goff DC. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006, 18(2):99-105. 10.1080/10401230600614538, 16754415.
32. McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Jarvelin MR, Chant D, Isohanni M. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004, 67(2-3):237-245. 10.1016/j.schres.2003.08.005, 14984883.
33. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res 2003, 63(1-2):73-78. 10.1016/S0920-9964(02)00435-8, 12892860.
34. Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr 2008, 88(2):500S-506S.
35. Burgaz A, Akesson A, Oster A, Michaelsson K, Wolk A. Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr 2007, 86(5):1399-1404.
36. Feron F, Burne TH, Brown J, Smith E, McGrath JJ, Mackay-Sim A, Eyles DW. Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005, 65(2):141-148. 10.1016/j.brainresbull.2004.12.007, 15763180.
37. Becker A, Eyles DW, McGrath JJ, Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res 2005, 161(2):306-312. 10.1016/j.bbr.2005.02.015, 15922058.
38. Domingo JL, Bocio A. Levels of PCDD/PCDFs and PCBs in edible marine species and human intake: a literature review. Environ Int 2007, 33(3):397-405. 10.1016/j.envint.2006.12.004, 17270272.
39. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002, 59(10):913-919. 10.1001/archpsyc.59.10.913, 12365878.
40. Mischoulon D, Best-Popescu C, Laposata M, Merens W, Murakami JL, Wu SL, Papakostas GI, Dording CM, Sonawalla SB, Nierenberg AA, Alpert JE, Fava M. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol 2008, 18(9):639-645. 10.1016/j.euroneuro.2008.04.011, 18539007.
41. Peet M, Horrobin DF. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatr Res 2002, 36(1):7-18. 10.1016/S0022-3956(01)00048-6, 11755456.
42. Peet M, Shah S, Selvam K, Ramchand CN. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J Biol Psychiatry 2004, 5(2):92-99. 10.1080/15622970410029917, 15179668.
43. Horrobin DF, Jenkins K, Bennett CN, Christie WW. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot Essent Fatty Acids 2002, 66(1):83-90. 10.1054/plef.2001.0338, 12051959.
44. Simopoulos A, Cleland L. Omega-6/Omega-3 Essential Fatty Acid Ratio:The Scientific Evidence. 2003, Basel: Karger AG, Simopoulos A.
45. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233(6):674-688. 10.3181/0711-MR-311, 18408140.
46. Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami HO, Gronberg H, Balter KA. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 2007, 120(2):398-405. 10.1002/ijc.22319, 17066444.
47. Walcott FL, Hauptmann M, Duphorne CM, Pillow PC, Strom SS, Sigurdson AJ. A case-control study of dietary phytoestrogens and testicular cancer risk. Nutr Cancer 2002, 44(1):44-51. 10.1207/S15327914NC441_6, 12672640.
48. Stattin P, Bylund A, Biessy C, Kaaks R, Hallmans G, Adlercreutz H. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 2004, 15(10):1095-1102. 10.1007/s10552-004-1480-7, 15801493.
49. Hedelin M, Klint A, Chang ET, Bellocco R, Johansson JE, Andersson SO, Heinonen SM, Adlercreutz H, Adami HO, Gronberg H, Balter KA. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control 2006, 17(2):169-180. 10.1007/s10552-005-0342-2, 16425095.
50. Hulthen K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002, 41(4):168-176. 10.1007/s00394-002-0373-3, 12242585.
51. Hibbeln JR, Makino KK, Martin CE, Dickerson F, Boronow J, Fenton WS. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 2003, 53(5):431-441. 10.1016/S0006-3223(02)01549-4, 12614996.
52. Saarni SE, Saarni SI, Fogelholm M, Heliovaara M, Perala J, Suvisaari J, Lonnqvist J. Body composition in psychotic disorders: a general population survey. Psychol Med 2008, 1-10.
53. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 2005, 162(1):12-24. 10.1176/appi.ajp.162.1.12, 15625195.
54. Perala J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsa E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppa T, Harkanen T, Koskinen S, Lonnqvist J. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007, 64(1):19-28. 10.1001/archpsyc.64.1.19, 17199051.
55. Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer 2003, 89(9):1672-1685. 10.1038/sj.bjc.6601314, 2394401, 14583769.
56. Astorg P, Arnault N, Czernichow S, Noisette N, Galan P, Hercberg S. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 2004, 39(6):527-535. 10.1007/s11745-004-1259-6, 15554151.
57. Sioen IA, Pynaert I, Matthys C, De Backer G, Van Camp J, De Henauw S. Dietary intakes and food sources of fatty acids for Belgian women, focused on n-6 and n-3 polyunsaturated fatty acids. Lipids 2006, 41(5):415-422. 10.1007/s11745-006-5115-5, 16933786.
58. Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003, 62(4):813-821. 10.1079/PNS2003297, 15018480.
59. Bogren M, Mattisson C, Isberg PE, Munk-Jorgensen P, Nettelbladt P. Incidence of psychotic disorders in the 50 year follow up of the Lundby population. Aust N Z J Psychiatry 44(1):31-39. 10.3109/00048670903393647, 20073565.
60. Varghese D, Scott J, McGrath J. Correlates of delusion-like experiences in a non-psychotic community sample. Aust N Z J Psychiatry 2008, 42(6):505-508. 10.1080/00048670802050595, 18465377.